EuroEspes Overview
- Year Founded
-
1991
- Status
-
Public
- Employees
-
26
- Stock Symbol
-
EEP
- Investments
-
2
- Share Price
-
$0.54
- (As of Thursday Closing)
EuroEspes General Information
Description
Euroespes SA is a biomedical research center offering medical, research, medical informatics and bioinformatics services. It offers medicine and personalized treatment for central nervous system disorders and researches genomic medicine. Other services offered by the company include genomics, digital diagnosis, diagnostic imaging, neuro-psychology, neuro-ophthalmology, nursing, epigenetics, clinical analysis and otorhinolaryngology.
Contact Information
Website
www.euroespes.comCorporate Office
- Santa Marta de Babío
- Bergondo
- 15165 A Coruna
- Spain
Corporate Office
- Santa Marta de Babío
- Bergondo
- 15165 A Coruna
- Spain
EuroEspes Stock Performance
As of 27-Oct-2022, EuroEspes’s stock price is $0.54. Its current market cap is $6.32M with 11.6M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.54 | $0.54 | $0.51 - $0.65 | $6.32M | 11.6M | 3.79K | -$0.02 |
EuroEspes Financials Summary
As of 31-Dec-2025, EuroEspes has a trailing 12-month revenue of $3.25M.
|
In Thousands, USD |
TTM 31-Dec-2025 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| Revenue | 3,251 | 3,251 | 3,148 | 3,196 |
| EBITDA | 747 | 747 | 498 | (991) |
| Net Income | 1 | 1 | (350) | (2,309) |
| Total Assets | 7,544 | 7,544 | 7,225 | 8,769 |
| Total Debt | 3,537 | 3,537 | 3,621 | 4,454 |
EuroEspes Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
EuroEspes Patents
EuroEspes Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2763025-T3 | Bioactive extract obtained from vicia faba and its use in the treatment and / or prevention of neurodegenerative diseases | Active | 29-Mar-2016 | ||
| EP-3225245-A1 | Bioactive extract obtained from vicia faba and its use in the treatment and/or prevention of neurodegenerative diseases | Active | 29-Mar-2016 | ||
| EP-3225245-B1 | Bioactive extract obtained from vicia faba and its use in the treatment and/or prevention of neurodegenerative diseases | Active | 29-Mar-2016 | ||
| ES-2128265-B1 | Genetic kit for the molecular characterization of alzheimer's disease. | Inactive | 04-Jun-1997 | ||
| ES-2128970-B1 | Method of obtaining cultures of microglial cells of adult rat and its applications. | Inactive | 20-Feb-1997 |
EuroEspes Signals
EuroEspes Investments & Acquisitions (2)
EuroEspes’s most recent deal was a Merger/Acquisition with EuroEspes Biotecnología. The deal was made on 01-Aug-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| EuroEspes Biotecnología | 01-Aug-2014 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| EuroEspes Biotecnología | Corporate | Other Pharmaceuticals and Biotechnology |
EuroEspes ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Services
Subindustry
Rank
Percentile
EuroEspes FAQs
-
When was EuroEspes founded?
EuroEspes was founded in 1991.
-
Where is EuroEspes headquartered?
EuroEspes is headquartered in A Coruna, Spain.
-
What is the size of EuroEspes?
EuroEspes has 26 total employees.
-
What industry is EuroEspes in?
EuroEspes’s primary industry is Biotechnology.
-
Is EuroEspes a private or public company?
EuroEspes is a Public company.
-
What is EuroEspes’s stock symbol?
The ticker symbol for EuroEspes is EEP.
-
What is the current stock price of EuroEspes?
As of 27-Oct-2022 the stock price of EuroEspes is $0.54.
-
What is the current market cap of EuroEspes?
The current market capitalization of EuroEspes is $6.32M.
-
What is EuroEspes’s current revenue?
The trailing twelve month revenue for EuroEspes is $3.25M.
-
What is EuroEspes’s annual earnings per share (EPS)?
EuroEspes’s EPS for 12 months was -$0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process